×
About 6,453 results

ALLMedicine™ Antimicrobial Susceptibility Center

Research & Reviews  2,404 results

Phenotypic and genotypic characterization of multi-drug resistance Pseudomonas aerugino...
https://doi.org/10.1097/MD.0000000000031373
Medicine He Y, Wu L et. al.

Dec 2nd, 2022 - Urinary tract infections (UTI) are commonest infections, especially in catheterized patients. It is responsible of mortality and morbidity among hospitalized patients. The objectives of the study were to demonstrate the virulence factors and their...

Modified Drug-Susceptibility Testing and Screening Culture Agar for Colistin-Susceptibl...
https://doi.org/10.1128/jcm.01399-22
Journal of Clinical Microbiology; Kananizadeh P, Tada T et. al.

Nov 30th, 2022 - Three isolates of the Enterobacter cloacae complex harboring mcr-9, a member of the colistin resistance mcr gene family encoded on plasmids, were susceptible to colistin, with MICs of 0.125 to 0.5 μg/mL in standard broth microdilution (BMD) tests ...

Microbiological and clinical characteristics of invasive Group B Streptococcal blood st...
https://doi.org/10.1186/s12879-022-07801-9
BMC Infectious Diseases; Ali M, Alamin MA et. al.

Nov 27th, 2022 - Group B Streptococci (GBS) colonize almost one third of human gastrointestinal and genitourinary tracts, particularly in females. The aim of this study is to evaluate the epidemiology, microbiological characteristics, and clinical outcomes of inva...

Opposite evolution of pathogenicity driven by in vivo wzc and wcaJ mutations in ST11-KL...
https://doi.org/10.1016/j.drup.2022.100891
Drug Resistance Updates : Reviews and Commentaries in Ant... He J, Shi Q et. al.

Nov 26th, 2022 - To investigate the in vivo evolution of the mucoid-phenotype of ST11-KL64 carbapenem-resistant Klebsiella pneumoniae (CRKP) isolated from the same patients and gain insights into diverse evolution and biology of these strains. Whole genome sequenc...

Deciphering variable resistance to novel carbapenem-based β-lactamase-inhibitor combina...
https://doi.org/10.1016/j.cmi.2022.11.011
Clinical Microbiology and Infection : the Official Public... Di Pilato V, Principe L et. al.

Nov 23rd, 2022 - Carbapenemase-producing Enterobacterales (CPE) represent a major cause of difficult-to-treat infections worldwide. The novel β-lactam/β-lactamase inhibitor combinations (BLICs), including ceftazidime/avibactam (CZA), meropenem/vaborbactam (MVB), a...

see more →

Guidelines  3 results

Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985752
Antimicrobial Agents and Chemotherapy; Pogue JM, Jones RN et. al.

Nov 27th, 2019 - The polymyxins are important agents for carbapenem-resistant Gram-negative bacilli. The United States Committee on Antimicrobial Susceptibility Testing breakpoint recommendations for colistin and polymyxin B are that isolates of Pseudomonas aerugi...

The 2018 Lebanese Society of Infectious Diseases and Clinical Microbiology Guidelines f...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441166
BMC Infectious Diseases; Haddad N, Kanj SS et. al.

Mar 31st, 2019 - The Lebanese Society of Infectious Diseases and Clinical Microbiology (LSIDCM) is involved in antimicrobial stewardship. In an attempt at guiding clinicians across Lebanon in regards to the proper use of antimicrobial agents, members of this socie...

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437259
Pharmacotherapy Tsuji BT, Pogue JM et. al.

Feb 3rd, 2019 - The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage thera...

see more →

Drugs  26 results see all →

Clinicaltrials.gov  81 results

Risk Factors for Pyogenic Liver Abscess With Carbapenem-resistant Klebsiella Pneumoniae: A Matched Case-control Study
https://clinicaltrials.gov/ct2/show/NCT05521139

Aug 30th, 2022 - Pyogenic liver abscess (PLA) is a complication of infectious disease, and the most common pathogen of PLA is Klebsiella pneumoniae, while PLA caused by Carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a threat to public health. For ach...

Supplemental Perioperative Oxygen to Reduce Surgical Site Infection After High Energy Fracture Surgery
https://clinicaltrials.gov/ct2/show/NCT01798810

Jul 29th, 2022 - Primary Objective To compare the proportion of surgical site infections within 6 months in patients treated with Supplemental Perioperative Oxygen compared to those treated without Supplemental Perioperative Oxygen. Secondary Objectives To compare...

INterest of the Negative Predictive Value of Integrons in Choosing a Narrow-spectrum Empirical anTibiotic Treatment vs Usual Empirical Antibiotic Treatment for Urinary Tract infectionS in the PEDia...
https://clinicaltrials.gov/ct2/show/NCT05066854

Jun 24th, 2022 - Urinary tract infections with fever are common in children and require primary health care management. Because of the risk of immediate evolution to a systemic infection with long-term renal scars, empirical antibiotic treatment is recommended. Th...

Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation
https://clinicaltrials.gov/ct2/show/NCT05405491

Jun 6th, 2022 - RESPIRE is a randomized, unblinded, controlled study to measure the impact of a strategy based on a PCR test on the adjustment of antimicrobial therapy in immunocompromised patients suspected with ventilator-associated or hospital-acquired pneumon...

Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures
https://clinicaltrials.gov/ct2/show/NCT03744728

Apr 22nd, 2022 - This study is designed as a prospective, randomized, open-label trial evaluating antimicrobial utilization, clinical outcomes, and healthcare costs among patients with positive blood cultures. Patients will be randomized to one of the following FD...

see more →

News  67 results

CDC: No Excess Pediatric Brain Infections During the Pandemic
https://www.medpagetoday.com/pediatrics/generalpediatrics/100765

Sep 16th, 2022 - A CDC report found no evidence for any unusual uptick in brain-related complications of bacterial infection among children across the country recently. Hospitalization for brain abscesses and empyemas declined after the beginning of the COVID-19 p...

2018 Medical Device Recalls | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/2018-medical-device-recalls

The list below contains recalls that were issued in 2018. 2018 Recalls Device Name Date GE Healthcare Recalls CareScape R860 Inspiratory Safety Guard Due to Risk of Disconnection from Breathing Circuit 12/12/18 Synaptive Medical Recalls BrightMatt...

Drug-Resistant Meningitis Found in Several US Patients
https://www.medscape.com/viewarticle/932621

Jun 18th, 2020 - During the past year, 11 US patients have presented with drug-resistant meningitis, according to a Health Alert Network health advisory from the Centers for Disease Control and Prevention (CDC). Neisseria meningitidis isolates from a patient's dem...

CMS’s new rule for antibiotic stewardship: The case of H. pylori
https://www.mdedge.com/gihepnews/article/217819/practice-management/cmss-new-rule-antibiotic-stewardship-case-h-pylori
David Y. Graham, MD, Hashem B. El-Serag, MD, MPH, AGAF

Feb 25th, 2020 - The Centers for Medicare and Medicaid Services (CMS) finalized a new regulation requiring all hospitals participating in its programs to establish antimicrobial stewardship programs by March 30, 2020 (https://federalregister. gov/d/2019-20736).

BioMerieux Recalls VITEK 2 Gram Positive Antimicrobial Susceptibility Testing (AST) Cards Due to False Results for some strains of methicillin-resistant Staphylococcus aureus (MRSA) | FDA
https://www.fda.gov/medical-devices/medical-device-recalls/biomerieux-recalls-vitek-2-gram-positive-antimicrobial-susceptibility-testing-ast-cards-due-false

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death Recalled Product Name: VITEK 2 Gram Positive Cefoxitin Screen; VITEK 2 Gram Positive AST for Oxacillin   Lot...

see more →